BASF and Poietis, a specialist in 3D laserassisted bioprinting, have signed an agreement on research and development in cosmetics.
Based on the combined expertise of both companies in tissue engineering and bioprinting, the agreement aims to apply the bioprinting technology of Poietis to improve BASF’s skin equivalent model Mimeskin.
The 3D laser-assisted bioprinting technology, by which organic tissues can be reproduced, allows for a precise positioning of the skin cells in three-dimensional structures. Through this, cells are cultivated within BASF’s skin model Mimeskin, which is a close equivalent to the original physiological tissue of human skin.
Poietis’ bioprinting technology refines BASF’s skin model Mimeskin due to its advanced printing resolution. The laser-assisted bioprinting technology will be used in a first step to allow for automated reproduction of Mimeskin, followed by more advanced models containing additional cell types.
